TrialHuman vaccines & immunotherapeutics2026

Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adults.

Amanda K Rudman Spergel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.